Doctors say clot treatment advice key to US resuming J&J COVID vaccines - Reuters

Resuming the use of Johnson & Johnson's (JNJ.N) COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as alerting vaccine rec… https://www.reuters.com/business/healthcare-pharmaceuticals/doctors-say-clot-treatment-advice-key-us-resuming-jj-covid-vaccines-2021-04-19/